CHROMADEX CORP
Acción · US1710774076 · CDXC · A2AG5N (XNCM)
9,09 USD
01.08.2025 21:31
Cotizaciones actuales de CHROMADEX CORP
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
NAGE
|
USD
|
01.08.2025 21:31
|
9,09 USD
| -0,26 USD
-2,78 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | -2,57 % | -29,04 % | 20,24 % | 61,46 % | 231,75 % | 79,64 % |
Perfil de la empresa para CHROMADEX CORP Acción
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Datos de la empresa
Nombre CHROMADEX CORP
Empresa ChromaDex Corporation
Símbolo CDXC
Sitio web
https://www.chromadex.com
Mercado principal
NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Mr. Frank Louis Jaksch Jr.
Capitalización de mercado 612 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 10900 Wilshire Boulevard, 90024 Los Angeles
Fecha de OPV 2008-06-25
Splits de acciones
Fecha | Split |
---|---|
13.04.2016 | 1:3 |
Cambios de identificador
Fecha | De | A |
---|---|---|
19.03.2025 | CDXC | NAGE |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | OCD1.F |
NASDAQ | CDXC |
NASDAQ | NAGE |
Otras acciones
Los inversores que tienen CHROMADEX CORP también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.